Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Raven biosciences ApS
APS
Active
CVR 39085127
Åbogade 15, 3.
Computer consultancy and computer facilities management activities · NACE 6220
Est. 2017
8 employees
ravenbiosciences.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 5,1M
-28% vs 2023
EBITDA margin
-24.4%
-270% vs 2023
Equity ratio
34.0%
Financial strength
Net profit 2024
DKK -925K
-315% vs 2023
EBITDA — year on year
DKK millions
0M
1M
2M
3M
4M
0M
2018
1M
+100%
2019
0M
-100%
2020
1M
+100%
2021
3M
+200%
2022
1M
-67%
2023
-1M
-200%
2024
Key figures
Annual report 2024
Revenue
DKK 5,1M
-28%
EBITDA
DKK -1,2M
-270%
Net profit
DKK -925K
-315%
Total assets
DKK 5,3M
-28%
Equity
DKK 1,8M
-54%
Employees
8
—
Company information
Legal name
Raven biosciences ApS
CVR number
39085127
Legal form
Anpartsselskab
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
9. november 2017
Share capital
DKK 50.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af alle direktørerne i forening.
Company purpose
Selskabets formål er at udvikle software og yde konsulentassistance.
Contact
Address
Åbogade 15, 3.
Phone
+4523490227
Email
kgj@ravenbiosciences.com
Website
ravenbiosciences.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer consultancy and computer facilities management activities
Companies in Aarhus
All Denmark companies
Revenue
DKK millions
0M
4M
7M
11M
15M
2M
2018
5M
2019
2M
2020
6M
2021
13M
2022
7M
2023
5M
2024
EBITDA
DKK millions
0M
1M
2M
3M
3M
0M
2018
1M
2019
0M
2020
1M
2021
3M
2022
1M
2023
-1M
2024
Income statement
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Revenue
1.782
4.787
2.244
5.957
12.670
7.055
5.095
Staff expenses
-1.362
-2.893
-2.426
-2.480
-4.000
-5.260
-5.357
EBITDA
420
532
-322
918
3.483
733
-1.243
Depreciation & amort.
-0
-0
-0
-0
-0
-0
-0
EBIT
420
532
-322
918
3.483
733
-1.243
Net financials
0
-2
-6
-8
-306
-331
56
Profit before tax
420
530
-328
910
3.177
402
-1.186
Tax
92
117
-72
200
699
-27
-261
Net profit
328
413
-255
710
2.478
430
-925
Balance sheet
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Total assets
1.203
1.122
975
2.987
7.939
7.285
5.278
Equity
378
669
413
1.015
3.493
3.922
1.797
Long-term debt
0
0
0
0
0
0
0
Short-term debt
825
454
561
1.972
4.446
3.363
3.481
Total debt
825
454
561
1.972
4.446
3.363
3.481
Financial ratios
5-year trend
EBITDA margin
-24.4%
This company
15.8%
Market median
-254% vs market
2018
2024
Equity ratio
34.0%
This company
38.2%
Market median
+11% vs market
2018
2024
Return on equity
-51.5%
This company
18.4%
Market median
-380% vs market
2018
2024
Net profit margin
-18.2%
This company
8.1%
Market median
-325% vs market
2018
2024
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
2018
2024
Debt / equity
1.94×
This company
0.62×
Market median
-213% vs market
2018
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-11-09 – 2018-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Roald Forsberg
Individual
50.0%
50.0%
2017
InnoFoss Holding ApS
Company
50.0%
50.0%
2022
Kenneth Graabek Johansen
Individual
50.0%
50.0%
2017
KGJ Invest ApS
Company
50.0%
50.0%
2022
mravn holding ApS
Company
10.0%
10.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Raven biosciences ApS also hold positions in
0
other companies.
Person
Role here
Other companies